Key statistics
On Tuesday, Swedish Orphan Biovitrum AB (publ) (B6E:HAN) closed at 35.74, -9.24% below its 52-week high of 39.38, set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 35.74 |
|---|---|
| High | 35.74 |
| Low | 35.74 |
| Bid | -- |
| Offer | -- |
| Previous close | 36.08 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 357.41m |
| Free float | 197.59m |
| P/E (TTM) | 299.66 |
| Market cap | 138.89bn SEK |
| EPS (TTM) | 1.30 SEK |
Data delayed at least 15 minutes, as of Mar 03 2026 07:01 GMT.
More ▼
- Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
- Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
